OTHER INFORMATION
−Removed: Item 5.02 Departure of Directors or Certain Officers;
−Removed: Election of Directors;
−Removed: Appointment of Certain Officers;
−Removed: Compensatory Arrangements of Certain Officers.
−Removed: In May 2019, the named executive officers and principal financial officer, or, collectively, the Officers, agreed to a voluntary 10% salary reduction.
−Removed: On August 3, 2020, the Company’s board of directors approved revisions to the base salary amounts of the Officers to return them to the salary amounts in effect prior to the voluntary salary reduction in 2019.
−Removed: As a result, the base salary rate to be paid to the Officer’s for the remainder of 2020 is as follows:
−Removed: Bristow, President and Chief Executive Officer, $304,219;
−Removed: Keuer, Chief Operating Officer, $303,000;
−Removed: Christopher D.
−Removed: Ozeroff, Secretary, Senior Vice President and General Counsel, $297,343;
−Removed: Selby, Vice President, Finance, $247,200.
+Added: Not applicable.
EXHIBIT INDEX
9 unchanged sentences
Form of Common Stock Certificate .
−Removed: Form of Pre-Funded Warrant .
−Removed: Form of Stock Purchase Agreement between the Company and the Purchasers, dated as of June 2, 2020 .
Amendment No.
6 unchanged sentences
and JonesTrading Institutional Services LLC .
+Added: Office Lease Agreement, effective August 7, 2020, between ARCA biopharma, Inc.
+Added: and Potens Partners LLC .
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
−Removed: Incorporated by Reference (1)
Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
−Removed: 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
+Added: 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 .
+Added: Incorporated by Reference (1)
XBRL Instance Document (filed electronically herewith)
9 unchanged sentences
(Principal Financial and Accounting Officer)
−Removed: August 5, 2020
+Added: November 2, 2020
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.